Price alert —
Sign in to get a one-time email the moment TXG crosses your price. Free accounts included.
Sign in / create a free account10x Genomics, Inc. is a healthcare company listed in the US.
TXG last traded at $43.74, down 1.7% on the day; that's in the upper part of its 52-week range ($15.90–$46.32). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
Our cash-flow model pegs fair value near $15.88 (fair range $16–$21); today's price sits 136% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 3.82 (antifragile)
- ✓ Current ratio 4.46 (antifragile)
- ✓ Debt/equity 0.31 (antifragile)
- ⚠ Negative retained earnings
- ⚠ Stock comp 17% of revenue (heavy dilution)
Price implies ~15% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
TXG is a $5.4 billion company, the stock is trading near the top of its 52-week range.